Logo

OncoDNA Signs Armenian Distribution Deal With PromTest

Mar 28, 2018 | staff reporter

NEW YORK (GenomeWeb) – Belgian diagnostics firm OncoDNA said on Tuesday that it has signed a distribution deal for its tumor profiling products in Armenia with PromTest.

OncoDNA's product line includes the OncoDeep solid tumor test, OncoTrace and OncoSelect liquid biopsy tests, the OncoStrat&Go solid and liquid biopsy combination test, and OncoKDM data interpretation and reporting software.

Specific terms of the deal were not disclosed.

OncoDNA has signed a number of distribution agreements for its products in recent months, including ones with NM Genomix in Bulgaria, Genext in the Russian Federation, CyberKnife Sigulda in Latvia, and Everything Genetic in the UK.

Filed under

Cancer
Business News
Molecular Diagnostics
distribution agreement
Breaking News
The Scan

Machine Learning Helps ID Molecular Mechanisms of Pancreatic Islet Beta Cell Subtypes in Type 2 Diabetes

The approach helps overcome limitations of previous studies that had investigated the molecular mechanisms of pancreatic islet beta cells, the authors write in their Nature Genetics paper.

Culture-Based Methods, Shotgun Sequencing Reveal Transmission of Bifidobacterium Strains From Mothers to Infants

In a Nature Communications study, culture-based approaches along with shotgun sequencing give a better picture of the microbial strains transmitted from mothers to infants.

Microbial Communities Can Help Trees Adapt to Changing Climates

Tree seedlings that were inoculated with microbes from dry, warm, or cold sites could better survive drought, heat, and cold stress, according to a study in Science.

A Combination of Genetics and Environment Causes Cleft Lip

In a study published in Nature Communications, researchers investigate what combination of genetic and environmental factors come into play to cause cleft lip/palate.